CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Open-market sale Director sold 171,003 shares at an average $149.11 ($25,497,840)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $213.67 ($4,273,311)
- 4 Open-market sale CBO & COO sold 25,000 shares at an average $215.20 ($5,379,940)
- 4 Open-market sale General Counsel and Secretary sold 27,500 shares at an average $204.94 ($5,635,944)
- 4 Shares withheld for taxes CBO & COO gave up 9,392 shares (to pay taxes)
- 4 Exercise or conversion Chief Executive Officer acquired 13,800 shares (option exercise)
- 4 Open-market sale Executive VP, Head of R&D sold 23,551 shares at an average $149.23 ($3,514,610)
- 4 Open-market sale Director sold 15,000 shares at an average $148.95 ($2,234,266)
- 4/A Open-market sale Director sold 33,000 shares at an average $143.35 ($4,730,448)
- 4 Open-market sale Director sold 33,000 shares at an average $143.35 ($4,730,448)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $142.29 ($2,845,782)
- 4 Exercise or conversion General Counsel and Secretary acquired 22,026 shares (option exercise)
- 4 Open-market sale Director sold 171,004 shares at an average $154.53 ($26,424,505)
- 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
- 4 Open-market sale President sold 100,000 shares at $125.00 ($12,500,000)
- 4 Other disposition Director disposed of 518,519 shares (other)
- 4 Open-market sale President sold 25,000 shares at $100.00 ($2,500,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 26 · 502 filings